Jeevan Scientific Technology Stocks Witness Spurt in Volume after USFDA Audit
DSIJ Intelligence / 13 Jun 2017
Jeevan Scientific Technology provides a broad range of clinical research services for healthcare/pharmaceutical industries across the globe.
Jeevan Scientific Technology provides a broad range of clinical research services for healthcare/pharmaceutical industries across the globe. On Tuesday, it was locked at 5% upper circuit at Rs 39.80 after successful completion of first audit by the US health regulator. The stock also witnessed a spurt in the volume by more than 2.51 times.
On Monday, the US Food and Drug Administration conducted an un-announced audit of company's corporate and clinical pharmacology centre facilities. The purpose of this audit was to review the BA/BE studies, the company informed.
According to a BSE filing, the auditors were pleased with procedures and processes which resulted with no 483 observation.
The stock has delivered more than 30% returns in a period of one year. It has underperformed BSE small-cap and Nifty Service Sector index over the same period.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.